Traditional Chinese Medicine Preparation Combined Therapy May Improve Chemotherapy Efficacy: A Systematic Review and Meta-Analysis

Abstract

Background. Whether traditional Chinese medicine preparation combined therapy can improve the efficacy of chemotherapy is controversial. This meta-analysis evaluates the efficacy of traditional Chinese medicine preparation combined with chemotherapy. Method. Three databases were searched from inception through August 2018. Eligible randomized controlled trials (RCTs) involving the combined treatment of chemotherapy and traditional Chinese medicine preparation compared to chemotherapy alone for treating cancer were retrieved. The methodological quality of the included RCTs was assessed with Cochrane Collaboration’s risk of bias assessment tool. Meta-analysis was adopted to make comprehensive comparisons between the experimental and control groups. Results. Four RCTs were included in this review, comprising 256 subjects. The majority of the RCTs were judged as being of poor methodological quality. Meta-analysis showed that the combination of traditional Chinese medicine preparation and chemotherapy appeared to be more effective than chemotherapy alone, for the treatment of cancer, as assessed by the disease control rate (RR: 1.41, 95% CI: 1.11 to 1.79) and the objective response rate (RR: 2.71, 95% CI: 1.28 to 5.77). There were no statistically significant differences between the groups in terms of bone marrow suppression (RR: 0.88, 95% CI: 0.57 to 1.37) or gastrointestinal reaction (RR: 1.12, 95% CI 0.75 to 1.69). Conclusions. Traditional Chinese medicine preparation combined with chemotherapy may improve objective response rates and disease control rates more than chemotherapy alone. The evidence that combined traditional Chinese medicine preparation can reduce the side effects of chemotherapy is insufficient. More rigorous randomized controlled trials are needed to confirm these conclusions.

WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11

“…Zou and colleagues [15] found that PHY906 exerts a protective effect in IBD by down-regulated production of pro-inflammatory cytokines and suppression of the NF-κB signaling pathway. Several clinical studies have demonstrated that TCM, as an alternative treatment for cancer, can reduce the incidence of bone marrow suppression and gastrointestinal reactions in chemotherapy [16][17][18]. In addition to mitigate the side effects of chemotherapy, the combination of chemotherapy and TCM also improves the chemosensitivity of diseases.…”

Medicinal Plants and Mushrooms with Immunomodulatory and Anticancer Properties—A Review on Hong Kong’s Experience

“…The conclusions drawn from most of these studies suggest that, for cancer patients, TCM can be useful and effective, helping to control the disease, prolonging survival time, alleviating side effects of chemotherapy and radiotherapy, and improving the quality of life [ 95 ]. One systematic review summarized that traditional Chinese medicine preparations, combined with chemotherapy, may improve the objective response rates and disease control rates more than chemotherapy alone [ 96 ]. Throughout these years, pharmacognosists, pharmacologists, and biochemists are anticipating more and more scientific evidence on the efficacies of medicinal herbs, to be gained through modern pharmacological research approaches.…”

Beneficial Actions of Orostachys japonica and Its Compounds against Tumors via MAPK Signaling Pathways

“…However, whether using a traditional herbal formula as an adjuvant therapy to conventional drugs can potentiate the efficacy of chemotherapy and reduce adverse effects is controversial. A recent systematic review raised questions regarding the efficacy of herbal decoctions combined with conventional chemotherapeutic agents [ 79 ]. However, combinational therapeutic strategies to enhance anticancer properties and decrease side effects have received attention.…”